CRYOPDP

Every discovery begins with a question. What if this one works? At the European Society for Medical Oncology Congress, Bristol Myers Squibb and SystImmune revealed the first global results of Iza-bren, a bispecific antibody-drug conjugate being studied in advanced solid tumours. The early data showed promising activity and a manageable safety profile in patients who had already undergone several treatments. Each result reflects years of research and a shared goal to improve the lives of those facing tough challenges cancers. Behind every study, dependable logistics guarantee that samples and therapies arrive safely and punctually. CRYOPDP supports maintaining this continuity, linking science to patients worldwide. Discover more about this study here: https://lnkd.in/dJZQ9mwS. #CancerResearch #Oncology #ClinicalTrials #HealthcareLogistics #LifeSciences #Pharma #Biotech #BristolMyersSquibb #CRYOPDP

What does it take to move a therapy that can change a life? Cell and gene therapies bring new possibilities for patients who once had none. But their journey is as delicate as the science itself. These living materials depend on precise temperatures, seamless timing, and complete control. Every movement must be planned, monitored, and secured. Our teams combine expertise and technology to keep every therapy safe from lab to patient, ensuring its integrity and purpose reach those waiting for treatment. When innovation meets care, every delivery becomes a step toward healing. To learn more about our cell and gene therapy logistics solutions, click here: https://lnkd.in/dUnGtEzz. #CellandGeneTherapy #HealthcareLogistics #ColdChain #TemperatureControlled #LifeSciences #ClinicalTrials #PharmaSupplyChain #Biotech #CRYOPDP

How far can science go when hope leads the way? At #ESMO25, Daiichi Sankyo shared early results from DS-3939, a new therapy being developed for advanced cancers. It targets TA-MUC1, a protein expressed in several solid tumours, and has shown encouraging activity in early trials. Progress like this depends on more than research. It relies on the invisible work that keeps every sample and treatment safe on its way to patients. That is where CRYOPDP plays a quiet but vital role, connecting science to the people it serves. Read the full story here: https://lnkd.in/dbwhfptJ. #CancerResearch #Oncology #ClinicalTrials #HealthcareLogistics #LifeSciences #Pharma #Biotech #DaiichiSankyo #CRYOPDP

Every discovery begins with trust. At ASCO 2025, MD Anderson revealed five new studies that could transform the treatment of cancers such as thyroid, colorectal, and rare leukaemias. Each breakthrough begins long before results are shared. It starts with the safe movement of every sample, every therapy, every detail. CRYOPDP supports the invisible link that connects science to care. Every clinical study relies on materials that must travel safely from trial sites to labs and back again. By protecting biological samples and therapies at every stage, we help ensure research remains reliable and enable innovations to reach patients in time. Discover more about these studies and how logistics keeps research moving: https://lnkd.in/gsMAwd6J. #CancerResearch #ClinicalTrials #ASCO2025 #LifeSciences #Oncology #Pharma #Research #HealthcareLogistics #CRYOPDP

Dr Tobias Meyer, CEO of DHL, was in Mumbai with Wasim Dingankar and our India team. The visit strengthened collaboration and brought everyone closer to the daily work in the region. India is an integral part of our global network for pharma, biotech and clinical research. Time with the local team supports our shared goal of improving service and operational quality nationwide. We appreciate the collaboration between all teams involved. #healthcarelogistics #coldchain #lifesciences #pharma #biotech #clinicaltrials #qualitymatters #globalnetwork #cryopdp #dhlhealthlogistics

Every child deserves a safe start in life, access to healthcare, and the chance to grow surrounded by care and hope. This day reminds us that protecting children's health is not only about medicine, but also about the systems and people who make it reach them in time. When care moves safely, children can dream bigger, live healthier, and look forward to a future filled with possibilities. #UniversalChildrensDay #UNChildrensDay #ChildHealth #HealthcareForAll #GlobalCare #TogetherWeSaveLives #Hope #FutureGenerations #CRYOPDP

Progress in treatment-resistant cancer research. Early results from a new antibody-drug conjugate, DB-1310, show promising responses in patients with advanced solid tumours who have exhausted standard therapies. Nearly half of those with EGFR-mutant lung cancer experienced tumour reduction, supported by a manageable safety profile and improved survival outcomes. Reliable logistics are essential for progress in discoveries like these. CRYOPDP guarantees the secure transport of biological samples and investigational medicines, supporting research teams in maintaining stability, compliance, and trust at every stage of study. See how dependable logistics support scientific progress and patient care: https://lnkd.in/dFKNz4xD. #Oncology #ClinicalTrials #CancerResearch #LungCancer #SolidTumors #LifeSciences #Pharma #HealthcareLogistics #CRYOPDP

Cell and gene therapies are transforming medicine and helping people in ways that it wasn't possible before!  Moving them is complex. Each shipment contains living material that must arrive in precisely the same condition as when it left the lab. Temperature, timing and coordination decide everything. Behind every delivery is a story of precision, care, and responsibility that sustains science on its journey to the patient. Read here: https://lnkd.in/d5ufE4W3 #CellandGeneTherapy #CryogenicShipping #HealthcareLogistics #ClinicalTrialSupply #ColdChain #LifeSciences #PharmaLogistics #Biotech #CRYOPDP

Colorectal cancer research is setting new directions for care. Recent Phase 3 trials have revealed results that could change how colorectal cancer is treated, providing new evidence to inform future therapies and enhance patient outcomes. These findings represent an important step in refining treatment strategies for one of the most common cancer types worldwide. Behind every medical advance is careful coordination. CRYOPDP helps clinical studies move forward by keeping each sample and therapy during transit between sites. This effort supports researchers and healthcare teams in bringing effective treatments closer to those who need them. Learn more about how reliable logistics help shape tomorrow's oncology treatments: https://lnkd.in/dG99ZaKE. #Oncology #ClinicalTrials #ColorectalCancer #CancerResearch #LifeSciences #Pharma #HealthcareLogistics #TemperatureControlled #CRYOPDP

Promising results for a rare and aggressive blood cancer. Researchers at MD Anderson Cancer Centre have shared encouraging findings from a Phase I/II trial of the new antibody-drug conjugate, pivekimab sunirine (PVEK), in patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN). The study showed an overall response rate of 85% and a complete response rate of 70% in newly diagnosed patients, suggesting a new possible standard of care for this difficult-to-treat disease. Behind studies like this, precision and timing are everything. CRYOPDP helps research teams protect the integrity of each therapy and sample as they move between clinical sites, ensuring that science continues to progress safely toward better patient outcomes. Learn how reliable logistics help accelerate new therapies: https://lnkd.in/d6RaXyen. #Oncology #ClinicalTrials #CancerResearch #BloodCancer #LifeSciences #Pharma #HealthcareLogistics #TemperatureControlled #CRYOPDP